Summary.-The basal concentration of the tryptophan metabolite 3-hydroxyanthranilic acid (30HA), which has carcinogenic properties, was measured with an enzymatic method of determination which allowed separate measurement of free and conjugated 30HA. The concentration of free 30HA in untreated bladder cancer patients was significantly (P < 0.001) higher than in a healthy control group, but after local therapy the concentration was significantly lower than before treatment (P < 0-01). The concentration of conjugated 30HA was nearly constant in the three groups. It was concluded that other factors than a genetic determined abnormality might be operating in bladder cancer patients which could lead to an abnormal concentration of 30HA in their urine.
'rHE role of tryptophan metabolites in the aetiology of human urinary bladder cancer has been the subject of numerous investigations. Twenty-two years ago a relationship was suggested by Dunning, Curtis and Maun (1950) , who showed that a high incidence of bladder tumours resulted when rats were fed 2-acetylaminofluorene combined with DL-tryptophan. Several primary aromatic amine tryptophan metabolites, with a structure similar to known environmental human bladder carcinogens, are present in human urine (Brown and Price, 1956) . Direct application to the mouse bladder of these metabolites by the " pellet technique " confirmed the carcinogenic activity of several of them (Bryan, 1971) . Recently, Radomski, Glass and Deichmann (1971) have given evidence supporting the role of tryptophan in bladder carcinogenesis by feeding 7 times the normal daily intake of DL-tryptophan to beagle dogs for periods of 3 5 months to 7 years. Marked local hyperplasia of the transitional bladder epithelium was observed in all cases.
Several clinical studies of the metabolism of tryptophan have been carried out in patients with bladder cancer (Brown et al., 1960; Price and Brown, 1962; Benassi, Perissinotto and Allegri, 1963; Kochen and Hochberg, 1970) . In these investigations one or more metabolites were determined in samples of 24-hour urine. In most of the studies, loading with an oral dose of L-tryptophan was necessary because the analytical methods are working at lower limits of detection and sensitivity when used on basal urines. Because of the differences in method, it is difficult to compare the results obtained in the different laboratories. An abnormal metabolism was often observed in patients with spontaneous bladder cancer, but in other pathological conditions an abnormal excretion pattern was also found (Rose, .
Moreover, the excretion of metabolites is related to tryptophan intake, hormonal regulation of the pathway, intake levels of pyridoxine and metabolic individualitv (Albanese et al., 1972) . In a pilot study (unpublished) , we determined the metabolites 3-hydroxyanthranilic acid, 3-hydroxykynurenine and kynurenine using the methods of Brown and Price (1956) as modified by Heeley (1965) . A significantly lower amount of 3-hydroxyanthranilic acid was found in the (basal) 24-hour urine collections in a series (28) of patients after radiotherapy treatment for a bladder tumour, when compared with the amounts excreted in this series before treatment. The difference was not significant when a loading of 2 g of L-tryptophan was given to the patients.
Because the method has the disadvantage of inspecificity, a sensitive and specific enzymatic method for the determination of 30HA has been evaluated. With this method both unconjugated and conjugated 30HA have been estimated. The differences between groups of untreated bladder tumour patients, treated patients without detectable bladder malignancy and healthy controls were determined.
MATERIALS AND METHODS
The enzyme 30HA-oxidase (EC 1.13.1.6) converts 30HA to I-amino-4-formyl-butadiene, 1-2 dicarboxylate. This substance has a high molar extinction coefficient at 360 nm and the amount formed is directly proportional to the amount of 30HA.
The enzyme was obtained by the method of Wiss, Simmer and Peters (1956) with some modifications. Fresh or frozen calf liver (obtained from the local slaughterhouse) was homogenized with 5 parts of water in a household mixer (3 min). After centrifugation (3600 g; 30 min, 4°C) an acetone fractionation was performed at minus 10°C. The 45-55 vol % fraction was collected by centrifugation (3600 g; 10 min, -10°C) and the precipitate was lyophilized, and stored in vacuo at -80°C. Before use, part of this lyophilized precipitate was dissolved in 30 mmol/l sodium acetate buffer (pH 7.4), and ferrous sulphate (1 mmol/l) was added.
This solution was heated in a stainless steel beaker for exactly 5 min at 55°C. The heating procedure was terminated by cooling with ice. After centrifugation (3600 g; 10 min, 4°C) and discarding the precipitate, the enzyme solution was distributed over 1 ml glass ampoules, which were sealed and stored at -80TC for maximally 3 months before use.
The procedure results in a preparation which has 1700 times higher 30HA-oxidase activity per mg protein than the supernatant of the homogenate. The preparation was iinactive with 3-hydroxykynurenine, kynurenine and anthranilic acid.
For the determination of 30HA an internal standard method was used as proposed by Schievelbein and Buchfink (1967) . 1-5 ml of fresh urine and 8-5 ml of a 67 mmol/l oxygen saturated tris (hydroxymethyl)-amino methane buffer (pH 7-1) were transferred to a 40 mm lightpath glass cuvette. 0 5 ml of enzyme was mixed with 3.5 ml of the same -buffer and transferred into two 2 ml syringes. 'Both syringes were attached to an adaptor on the spectrophotometer (Optica CF4R), and from the adaptor 10 cm pieces of 1 6 mm Teflon tubing led to the bottom of the glass cuvette.
The reaction was started by injecting the contents of both syringes simultaneously (to). The increasing absorbance (E) at 360 nm was registrated on a recorder. Due to mixing turbulences it was impossible to estimate E during the first seconds after injection. Mixing of the enzyme with 30HA gives a small unreproducible change in the summed E's of the components. Because it is also impossible to estimate the zero time value from a blank, a mathematical method was used to estimate the total rise in E due to the formation ofthe reaction product. The method is illustrated in Fig. 1 . On the left side of the figure the directly recorded progress of the reaction is shown (arrow indicates the start to). Within 1 min a plateau in E is reached (E = A). When the values obtained for E from t = 7s until t = 25s are subtracted from A, and the resulting values D are plotted on a logarithmic scale (right side of Fig. 1 ) a straight line is obtained.
The maximum increase Do can be calculated by extrapolation of the line to to by a least square method. The concentration 30HA was calculated as Do/E.1 (E = molar extinction coefficient of the product = 47 000; 1 = lightpath) and correcting this value for urine dilution.
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Category C'" : controls-.This group was built up of hospital personnel and patients visiting the clinic for the follow-up of cured skin tumours. Because no differences could be found in the concentration of the metabolite between these groups, they were taken together in the control group. Category B ": patients with a bladder tnmour confirmied by cystoscopy but uwithout radiation therapy.-In general these patients had their urine tested during the first or second day after hospitalization. Category ' TB ": patients treated for a bladder tumour.-All patients in this group were free of bladder tumour, as examined by follow-up cystoscopy, at the moment of 30HA determination. Ten patients were analysed within 4 months after treatment, 9 after 5-8 months, 4 after 9-12 months and 5 after 2-12 years.
Nine patients in Group B were repeated in Group TB.
RESULTS
In Table I the results for the concentration of free, total (after hydrolysis) and conjugated (total minus free) are given for the 3 groups.
The accuracy of the determination of the total 30HA concentration is less than the accuracy of the free 30HA concentration (see Methods). While the accuracy of the determinations of free and total 30HA was +0 6 ,amol/l and +0 9 ,amol/l, sometimes a negative difference was found in the calculation of the concentration of conjugated 30HA. These values are considered as smaller than 0-4 ,amol/l. The data were tested for differences between the groups with the x2 test. The results are presented in Table II . To compare the mean concentration of free, total and conjugated 30HA, the concentration values were transformed to log1o (concentration + 1.0). Because the transformed values are distributed normally, the mean and 95% confidence limits could be calculated (Fig. 2) .
In Table III the groups are compared for different parameters.
The mean recovery of the added standard amount of 30HA during the analysis and during the hydrolysis was always between 80 and 90 % in the 3 groups.
There is no reason to assume that in any group substances are present in the urine which inhibit the enzyme, although in some urines the inhibition was remarkable. It was already presumed by Boyland and Williams (1956) that the metabolite could be excreted in the urine as the conjugated glucuronide, and that the carcinogenic activity followed after enzymatic hydrolysis by /,-glucuronidase in the urine.
Very recently it was confirmed by Watanabe, Ohkubo and Tamura (19972) and Watanabe and Minegisli (1972) that enzymatic formation of the glucuronide and also of the sulphuric ester of 30HA are possible. The enzymatic hydrolysis of both conjugates by 8-glucuronidase or arylsulphatase obtained from human urine, however, occurs slowly. We were able to show in an earlier study (Haye and van der Werf-Messing, 1962) that a relationship between high /f-glucuronidase levels in the urine and the occurrence of bladder cancer is not very likely. In all cases the determinations of free 30HA were carried out within one hour of urine collection, and in this way a shift from conjugated to free 30HA by the action of urinary enzymes was prevented as much as possible. From the statistical analysis of the results, the conclusion can be drawn that the concentration of free 30HA in the tumour group (B) is significantly higher than in the control (C) and locally cured (TB) group. The same conclusion can be drawn from the results for the total amount of 30HA, Emotional and )physical stress can stimulate the output of glucocorticoids by the adrenal glands, which results in a higher input of tryptophan into the kynurenine pathway, due to the activation of the tryptophan oxygenase (Rose and McGinthy, 1970) . Experimental tumours in animals can activate the tryptophan oxygenase as a result of the physical stress caused by bearing a tumour (Greengard, 1967) .
The significantly lower concentration of free 30HA in the TB group cannot support the hypothesis that a genetic abnormality is due to the abnormal concentration of 3011A in bladder tumour patients. The mean concentration of 30HA in the locally treated group (TB) tends to be somewhat higher than the concentration in the control group (C) but, as shown in Table III , there are also differences between the groups with respect to age, creatinine concentration and the time during which the urine was collected into the bladder. For future study it would be of interest to examine cases of recurrent local growth to see whether the concentration of 30HA returns to abnormal levels.
